Cost-effectiveness of hospital-based treatment compared with community treatment centres: an analysis of Korea National Health Insurance claims data.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 39053962.
- Also identified by DOI 10.1136/bmjopen-2023-079232 and PMC identifier 11284902.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We compared the cost-effectiveness of hospital-based treatment and that of community treatment centres (CTCs). We performed statistical analysis to compare the expenses incurred by COVID-19 patients who received hospital care with those incurred by COVID-19 patients who went to CTCs. A study was conducted on 411 530 COVID-19 inpatients and 243 329 CTC patients from January 2020 to December 2021. We calculated the probability of severe disease, hospitalisation period and medical expenses for inpatients and CTC patients. Subsequently, we analysed the cost-effectiveness of CTC compared with hospitalisation. Comparing medical expenses, CTC patients incurred 2 220 000 KRW on average, which is less than the expenses incurred by hospitalised COVID-19 patients. The study suggests that using a CTC may be more cost-effective than a hospital service alone.
Medical subject headings
- Cost-Benefit Analysis
- COVID-19
- Hospitalization